vs
CITIUS ONCOLOGY, INC.（CTOR）与赫兹（SELF）财务数据对比。点击上方公司名可切换其他公司
CITIUS ONCOLOGY, INC.的季度营收约是赫兹的1.2倍（$3.9M vs $3.2M），赫兹净利率更高（10.2% vs -140.3%，领先150.5%）
Citius Oncology是一家处于后期阶段的生物制药企业，专注于开发针对癌症患者的创新靶向疗法，核心管线覆盖血液恶性肿瘤和实体瘤领域的未满足医疗需求，主要服务北美及全球肿瘤诊疗市场。
赫兹控股（Hertz Global Holdings, Inc.），常称赫兹，是总部设在美国佛罗里达州埃斯特罗的汽车租赁企业，除核心赫兹品牌外，还运营达乐租车（Dollar Rent A Car）、萤火虫租车（Firefly Car Rental）和节约租车（Thrifty Car Rental）多个品牌，业务覆盖全球多地市场。
CTOR vs SELF — 直观对比
营收规模更大
CTOR
是对方的1.2倍
$3.2M
净利率更高
SELF
高出150.5%
-140.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $3.9M | $3.2M |
| 净利润 | $-5.5M | $322.8K |
| 毛利率 | 80.0% | — |
| 营业利润率 | -133.2% | 21.5% |
| 净利率 | -140.3% | 10.2% |
| 营收同比 | — | -0.9% |
| 净利润同比 | 16.9% | 282.5% |
| 每股收益（稀释后） | $-0.06 | $0.03 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTORSELF
| Q4 25 | $3.9M | $3.2M | ||
| Q3 25 | — | $3.2M | ||
| Q2 25 | — | $3.2M | ||
| Q1 25 | — | $3.1M | ||
| Q4 24 | — | $3.2M | ||
| Q3 24 | — | $3.2M | ||
| Q2 24 | — | $3.1M | ||
| Q1 24 | — | $3.0M |
净利润CTORSELF
| Q4 25 | $-5.5M | $322.8K | ||
| Q3 25 | — | $496.3K | ||
| Q2 25 | — | $664.2K | ||
| Q1 25 | — | $555.2K | ||
| Q4 24 | — | $84.4K | ||
| Q3 24 | — | $1.2M | ||
| Q2 24 | — | $591.5K | ||
| Q1 24 | — | $266.1K |
毛利率CTORSELF
| Q4 25 | 80.0% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率CTORSELF
| Q4 25 | -133.2% | 21.5% | ||
| Q3 25 | — | 22.6% | ||
| Q2 25 | — | 25.9% | ||
| Q1 25 | — | 23.1% | ||
| Q4 24 | — | 24.9% | ||
| Q3 24 | — | 27.3% | ||
| Q2 24 | — | 20.5% | ||
| Q1 24 | — | 19.5% |
净利率CTORSELF
| Q4 25 | -140.3% | 10.2% | ||
| Q3 25 | — | 15.4% | ||
| Q2 25 | — | 20.8% | ||
| Q1 25 | — | 17.8% | ||
| Q4 24 | — | 2.6% | ||
| Q3 24 | — | 36.9% | ||
| Q2 24 | — | 19.0% | ||
| Q1 24 | — | 8.8% |
每股收益（稀释后）CTORSELF
| Q4 25 | $-0.06 | $0.03 | ||
| Q3 25 | — | $0.04 | ||
| Q2 25 | — | $0.06 | ||
| Q1 25 | — | $0.05 | ||
| Q4 24 | — | $0.02 | ||
| Q3 24 | — | $0.10 | ||
| Q2 24 | — | $0.05 | ||
| Q1 24 | — | $0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $7.3M | $7.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $58.4M | $46.5M |
| 总资产 | $110.0M | $64.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CTORSELF
| Q4 25 | $7.3M | $7.4M | ||
| Q3 25 | — | $7.5M | ||
| Q2 25 | — | $7.5M | ||
| Q1 25 | — | $7.2M | ||
| Q4 24 | — | $7.2M | ||
| Q3 24 | — | $6.8M | ||
| Q2 24 | — | $7.0M | ||
| Q1 24 | — | $6.7M |
股东权益CTORSELF
| Q4 25 | $58.4M | $46.5M | ||
| Q3 25 | — | $46.9M | ||
| Q2 25 | — | $47.2M | ||
| Q1 25 | — | $47.3M | ||
| Q4 24 | — | $47.4M | ||
| Q3 24 | — | $48.1M | ||
| Q2 24 | — | $47.6M | ||
| Q1 24 | — | $47.8M |
总资产CTORSELF
| Q4 25 | $110.0M | $64.1M | ||
| Q3 25 | — | $64.8M | ||
| Q2 25 | — | $65.0M | ||
| Q1 25 | — | $65.1M | ||
| Q4 24 | — | $65.5M | ||
| Q3 24 | — | $66.3M | ||
| Q2 24 | — | $66.0M | ||
| Q1 24 | — | $66.1M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-7.4M | $4.5M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 13.86× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CTORSELF
| Q4 25 | $-7.4M | $4.5M | ||
| Q3 25 | — | $1.0M | ||
| Q2 25 | — | $1.3M | ||
| Q1 25 | — | $1.1M | ||
| Q4 24 | — | $4.3M | ||
| Q3 24 | — | $1.0M | ||
| Q2 24 | — | $1.2M | ||
| Q1 24 | — | $797.0K |
现金转化率CTORSELF
| Q4 25 | — | 13.86× | ||
| Q3 25 | — | 2.10× | ||
| Q2 25 | — | 2.02× | ||
| Q1 25 | — | 1.93× | ||
| Q4 24 | — | 51.30× | ||
| Q3 24 | — | 0.87× | ||
| Q2 24 | — | 2.11× | ||
| Q1 24 | — | 2.99× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
